MAPT and early-onset autosomal dominant Alzheimer disease: Diagnostic categories defined by the Amyloid-Tau-Neurodegeneration system within the continuum of the biological definition of Alzheimer’s disease, according to the 2018 National Institute on Aging and the Alzheimer’s Association Research Framework43,44.